NO-synthase gene and angiotensin receptor II (type 1) gene polymorphism and endothelium-related hemostasis in patients with coronary heart disease

被引：0

作者：

Zateyshchikov, DA ^{[1
]}

Minushkina, LO ^{[1
]}

Kudryashova, OY ^{[1
]}

Chistyakov, DA ^{[1
]}

Nosikov, VV ^{[1
]}

Barinov, VG ^{[1
]}

Tsimbalova, TE ^{[1
]}

Zateyshchikova, AA ^{[1
]}

Peresypko, MK ^{[1
]}

Sidorenko, BA ^{[1
]}

机构：

[1] Russia Cent Clin Hosp, Presidential Med Ctr, Moscow, Russia

来源：

KARDIOLOGIYA | 2000年 / 40卷 / 11期

关键词：

NO-synthase; gene; endothelium; hemostasis; venous occlusion test;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Relationship between polymorphisms of NO-synthase (NOS3) and angiotensin receptor II (type 1) (AT2R1) genes and endothelial-related hemostasis was assessed in 93 patients with coronary heart disease (52 males and 41 females; mean age 61+/-1,3 years). Venous-occlusion test (VOT) was performed to study endothelial hemostasis. Protein C, von Willebrand factor, plasminogen activator inhibitor (PAI) plasma concentrations were measured for antithrombotic endothelial function estimation To identify alleles of NOS3 and AT2R1 polymorphic markers we performed polymerase chain reaction amplification We found an association between Glu allele of the NOS3 gene (Glu298Asp polymorphism) and protein C consumption in VOT (chi (2)=6,83, p=0,033). Significant differences in protein C dynamics in VOT between patients with bb genotype of NOS gene and patients with aa and ab genotypes occurred (3,3+/-2,23% and -1,5+/-1,43%, p=0,028). In patients with protein C consumption in VOT frequency of AA genotype AT2R1 was significantly higher than AC and CC genotypes.

引用

页码：28 / 32

页数：5

共 10 条

[1] The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction [J].

Amant, C ;

Hamon, M ;

Bauters, C ;

Richard, F ;

Helbecque, N ;

McFadden, EP ;

Escudero, X ;

Lablanche, JM ;

Amouyel, P ;

Bertrand, ME .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (03) :486-490

[2]

Britten M. B., 1999, European Heart Journal, V20, P144

[3] NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS [J].

CELERMAJER, DS ;

SORENSEN, KE ;

GOOCH, VM ;

SPIEGELHALTER, DJ ;

MILLER, OI ;

SULLIVAN, ID ;

LLOYD, JK ;

DEANFIELD, JE .

LANCET, 1992, 340 (8828) :1111-1115

[4] Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro [J].

Henrion, D ;

Amant, C ;

Benessiano, J ;

Philip, I ;

Plantefeve, G ;

Chatel, D ;

Hwas, U ;

Desmont, JM ;

Durand, G ;

Amouyel, P ;

Lévy, BI .

JOURNAL OF VASCULAR RESEARCH, 1998, 35 (05) :356-362

[5] Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension [J].

Jeng, JR ;

Harn, HJ ;

Yueh, KC ;

Jeng, CY ;

Shieh, SM .

AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (02) :235-239

[6] Endothelial nitric oxide synthase gene is positively associated with essential hypertension [J].

Miyamoto, Y ;

Saito, Y ;

Kajiyama, N ;

Yoshimura, M ;

Shimasaki, Y ;

Nakayama, M ;

Kamitani, S ;

Harada, M ;

Ishikawa, M ;

Kuwahara, K ;

Ogawa, E ;

Hamanaka, I ;

Takahashi, N ;

Kaneshige, T ;

Teraoka, H ;

Akamizu, T ;

Azuma, N ;

Yoshimasa, Y ;

Yoshimasa, T ;

Itoh, H ;

Masuda, I ;

Yasue, H ;

Nakao, K .

HYPERTENSION, 1998, 32 (01) :3-8

[7]

Nakayama T, 1997, CLIN GENET, V51, P26

[8] Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels [J].

Wang, XL ;

Mahaney, MC ;

Sim, AS ;

Wang, J ;

Blangero, J ;

Almasy, L ;

Badenhop, RB ;

Wilcken, DEL .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :3147-3153

[9]

ZATEISHCHIKOV DA, 1992, B EKSP BIOL MED, V12, P605

[10]

ZATEYSHCHIKOV DA, 2000, KARDIOLOGIYA, V40, P14

← 1 →